Airway Clearance Devices Market– By Device Type, By Application, By Age Group, By End Use - Global Forecast, 2024 to 2032

Airway Clearance Devices Market Size

The global airway clearance devices market was valued at USD 648.6 million in 2023 and is expected to exhibit growth at a CAGR of 4.8% from 2024 to 2032 period. High market growth can be attributed to the continuous advancements in technology, rising prevalence of chronic respiratory diseases, growing geriatric population, and rising hospital-acquired infections, among other contributing factors.
 

Moreover, the aging global population is more prone to respiratory conditions due to declining lung function and increased susceptibility to infections. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population. This demographic trend drives demand for airway clearance devices, as they are crucial for improving respiratory health and quality of life among the elderly.
 

Furthermore, the increasing incidence of chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and bronchiectasis, is a significant driver. These diseases often lead to mucus build-up, making airway clearance devices essential for effective treatment and symptom management.
 

Airway clearance devices are medical devices designed to help remove mucus and clear the airways in individuals with respiratory conditions. These devices assist in improving lung function, preventing complications, and managing respiratory symptoms.
 

Airway Clearance Devices Market Trends

The airway clearance devices industry is experiencing several market trends that are shaping its growth and development. Factors such as growing adoption of portable and user-friendly devices, integration of smart and connected technologies, rising popularity of non-invasive therapies, and increased focus on home healthcare solutions, among other factors are boosting the industry growth.
 

• Further, there is a growing preference for portable, lightweight, and easy-to-use airway clearance devices, especially for home healthcare. These devices offer convenience and mobility, catering to patients who prefer at-home treatment over frequent hospital visits.
   
• Additionally, smart airway clearance devices with features like remote monitoring, data tracking, and mobile app integration are gaining traction. These innovations enable better patient adherence, real-time feedback, and improved outcomes by allowing healthcare providers to monitor therapy effectiveness remotely, thereby aforementioned factors are expected to drive the market.
   

Airway Clearance Devices Market Analysis

Based on device type, the market is classified into high frequency chest wall oscillation (HFCWO), flutter mucus clearance device, intrapulmonary percussive ventilation (IPV), mechanical cough assist devices, positive expiratory pressure (PEP), and other device types. The high frequency chest wall oscillation (HFCWO) segment generated the highest revenue of USD 242.6 million in 2023.
 

• HFCWO devices offer a non-invasive method of airway clearance, reducing the discomfort associated with traditional techniques. Their ease of use and ability to provide consistent therapy without the need for active patient involvement drive their adoption, particularly among elderly and pediatric patients.
   
• Moreover, innovations in these devices, including portable designs, wireless connectivity, and customizable therapy settings, enhance convenience and patient compliance. Advanced models with noise reduction and ergonomic features further improve user experience.
   

Based on application, the market is classified into chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, neuromuscular, and other applications. The chronic obstructive pulmonary disease (COPD) segment dominated the market in 2023 with a market share of 42.1%.
 

• The segment is driven by the increasing global prevalence of chronic obstructive pulmonary disease (COPD), which is one of the leading causes of morbidity and mortality worldwide. Factors such as rising tobacco consumption, exposure to air pollutants, occupational hazards, and aging populations contribute significantly to the growing burden of COPD. According to the World Health Organization (WHO), millions of people suffer from moderate to severe COPD, creating a substantial demand for airway clearance devices to manage symptoms and improve quality of life.
   
• Additionally, excessive mucus production and impaired clearance are common in COPD, leading to airway obstruction and exacerbations. Airway clearance devices, such as oscillatory positive expiratory pressure (OPEP) and high-frequency chest wall oscillation (HFCWO) devices, play a vital role in clearing mucus and reducing respiratory complications. This is anticipated to boost the segmental growth in the market.
   

Based on age group, the airway clearance devices market is segmented into adult and pediatric. The adult segment dominated the market in 2023 and is anticipated to reach USD 654 million by the end of forecast period.
 

• Adults undergoing thoracic or abdominal surgeries or those recovering from respiratory infections often require airway clearance therapy to prevent complications. This need drives the use of airway clearance devices in post-surgical and rehabilitation settings.
   
• Further, the adult population increasingly prefers home-based treatments for managing chronic conditions. Portable and easy-to-use airway clearance devices allow adults to perform effective therapy at home, reducing hospital visits and associated costs.
   

Based on end use, the market is segmented into hospital, homecare settings, ambulatory surgical centers, and other end users. The homecare settings segment dominated the market in 2023 and is anticipated to reach USD 540.5 million by the end of forecast period.
 

• Home-based airway clearance therapies are more cost-effective than frequent hospital visits or long-term inpatient care. This economic advantage appeals to both patients and healthcare systems, particularly in managing chronic conditions.
   
• Moreover, integration of airway clearance devices with telemedicine platforms enables healthcare providers to remotely monitor therapy adherence and effectiveness. This trend further supports the adoption of devices in homecare settings.
   

North America airway clearance devices market accounted for USD 254.6 million market revenue in 2023 and is anticipated to grow at a CAGR of 3% between 2024 to 2032 period.
 

• North America has a significant burden of chronic respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The high prevalence of these diseases drives the demand for advanced airway clearance solutions to improve patient outcomes.
   
• Further, the region boasts a well-developed healthcare system with widespread access to advanced medical technologies. This facilitates the adoption of airway clearance devices in both clinical and homecare settings, ensuring better patient management, leading to regional growth.
   

Germany airway clearance devices market is projected to grow remarkably in the coming years.
 

• German manufacturers and global players operating in Germany are investing in research and development to introduce innovative airway clearance devices. Features like compact designs, noise reduction, and wireless connectivity enhance usability and compliance.
   
• Moreover, the country has a high level of awareness about respiratory health, supported by educational campaigns and proactive healthcare policies. This leads to early diagnosis of respiratory conditions and timely intervention with airway clearance devices.
   

China holds a dominant position in the Asia Pacific market.
 

• Air pollution, particularly in urban areas, is a major health concern in China and contributes to a higher incidence of respiratory diseases. The increasing prevalence of pollution-related respiratory issues amplifies the need for airway clearance therapies to help individuals manage the resulting lung complications.
   
• The country's healthcare system is rapidly expanding and modernizing, with increasing access to advanced medical technologies. This creates a favorable environment for the adoption of airway clearance devices in hospitals, clinics, and homecare settings across the country.
   

Airway Clearance Devices Market Share

The airway clearance devices industry is highly competitive, with numerous key players offering innovative solutions to meet the growing demand for effective respiratory treatments. Major companies like Baxter International/Hill-Rom Holdings, Koninklijke Philips N.V., and Electromed dominate the market by providing a range of devices, such as HFCWO systems, positive expiratory pressure (PEP) devices, and mechanical insufflation-exsufflation devices. These companies are investing heavily in RandD to develop more effective, portable, and user-friendly devices to cater to the increasing prevalence of chronic respiratory diseases. Moreover, with a shift toward home care, the competition is intensifying in terms of product customization and cost-effective solutions.
 

Airway Clearance Devices Market Companies

Prominent players operating in the airway clearance devices industry include:

• ABM Respiratory Care
• Baxter International/Hill-Rom Holdings
• Dima Italia
• Dymedso
• Electromed
• ICU Medical
• Koninklijke Philips N.V.
• Mercury Medical
• Monaghan Medical
• Pari Medical
• Pneumo Care Health
• Sentec
• Tactile Medical
• Thayer Medical
• VORTRAN Medical
• VYAIRE MEDICAL
   

Airway Clearance Devices Industry News:

• In April 2023, Monaghan medical and Premier Inc. signed an agreement to provide respiratory devices to clinicians. Under the agreement Monaghan will provide Premier members with respiratory devices in two categories: Respiratory Therapy Medication Delivery devices and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices. This agreement may help the company to enhance its presence in the market and enhance their customer base.
   
• In January 2022, ICU Medical Inc. announced the acquisition of Smiths Medical from Smiths Group plc, a manufacturer of respiratory management devices and advanced medical devices. This acquisition helped the company to increase their product portfolio and acquire a new customer base.
   

The airway clearance devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Device Type

• High frequency chest wall oscillation (HFCWO)
• Flutter mucus clearance device
• Intrapulmonary percussive ventilation (IPV)
• Mechanical cough assist devices
• Positive expiratory pressure (PEP)
• Other device types

Market, By Application

• Chronic obstructive pulmonary disease (COPD)
• Bronchiectasis
• Cystic fibrosis
• Neuromuscular
• Other applications

Market, By Age Group

• Adult
• Pediatric

Market, By End Use

• Hospital
• Homecare settings
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE